Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Adoption of ASU No. 2016-13	Common stock and additional paid-in capital	Retained earnings	Retained earnings Adoption of ASU No. 2016-13	Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2022			11,045,186
Balance at beginning of period at Dec. 31, 2022	$ 228,923	$ (6,277)	$ 68,545	$ 204,343	$ (6,277)	$ (43,965)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	15,365			15,365
Net unrealized gain (loss) on securities available for sale, net of tax	937					937
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax	5					5
Net unrealized gain on hedging derivative instruments, net of tax	136					136
Comprehensive income (loss)	16,443			15,365		1,078
Cash dividends declared	(7,643)			(7,643)
Equity compensation expense	398		$ 398
Payment to repurchase common stock (in shares)			(12,379)
Payment to repurchase common stock	(249)			(249)
Issuance of restricted stock (in shares)			33,610
Proceeds from sale of common stock (in shares)			15,383
Proceeds from sale of common stock	$ 408		$ 408
Ending balance (in shares) at Jun. 30, 2023	11,081,800		11,081,800
Balance at end of period at Jun. 30, 2023	$ 232,003		$ 69,351	205,539		(42,887)
Beginning balance (in shares) at Mar. 31, 2023			11,074,182
Balance at beginning of period at Mar. 31, 2023	228,461		$ 68,941	202,036		(42,516)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,394			7,394
Net unrealized gain (loss) on securities available for sale, net of tax	(3,244)					(3,244)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax	1					1
Net unrealized gain on hedging derivative instruments, net of tax	2,872					2,872
Comprehensive income (loss)	7,023			7,394		(371)
Cash dividends declared	(3,878)			(3,878)
Equity compensation expense	213		$ 213
Payment to repurchase common stock (in shares)			(555)
Payment to repurchase common stock	(13)			(13)
Proceeds from sale of common stock (in shares)			8,173
Proceeds from sale of common stock	$ 197		$ 197
Ending balance (in shares) at Jun. 30, 2023	11,081,800		11,081,800
Balance at end of period at Jun. 30, 2023	$ 232,003		$ 69,351	205,539		(42,887)
Beginning balance (in shares) at Dec. 31, 2023	11,098,057		11,098,057
Balance at beginning of period at Dec. 31, 2023	$ 243,079		$ 70,182	211,925		(39,028)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	12,192			12,192
Net unrealized gain (loss) on securities available for sale, net of tax	(3,794)					(3,794)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax	5					5
Net unrealized gain on hedging derivative instruments, net of tax	433					433
Comprehensive income (loss)	8,836			12,192		(3,356)
Cash dividends declared	(7,906)			(7,906)
Equity compensation expense	450		$ 450
Payment to repurchase common stock (in shares)			(8,881)
Payment to repurchase common stock	(212)			(212)
Issuance of restricted stock (in shares)			32,859
Proceeds from sale of common stock (in shares)			17,604
Proceeds from sale of common stock	$ 421		$ 421
Ending balance (in shares) at Jun. 30, 2024	11,139,639		11,139,639
Balance at end of period at Jun. 30, 2024	$ 244,668		$ 71,053	215,999		(42,384)
Beginning balance (in shares) at Mar. 31, 2024			11,130,933
Balance at beginning of period at Mar. 31, 2024	242,624		$ 70,617	213,839		(41,832)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	6,171			6,171
Net unrealized gain (loss) on securities available for sale, net of tax	(553)					(553)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax	3					3
Net unrealized gain on hedging derivative instruments, net of tax	(2)					(2)
Comprehensive income (loss)	5,619			6,171		(552)
Cash dividends declared	(4,011)			(4,011)
Equity compensation expense	218		$ 218
Payment to repurchase common stock (in shares)			(850)
Proceeds from sale of common stock (in shares)			9,556
Proceeds from sale of common stock	$ 218		$ 218
Ending balance (in shares) at Jun. 30, 2024	11,139,639		11,139,639
Balance at end of period at Jun. 30, 2024	$ 244,668		$ 71,053	$ 215,999		$ (42,384)